Development of a novel l-histidine assay method using histamine dehydrogenase and a stable mutant of histidine decarboxylase.


Journal

Analytical biochemistry
ISSN: 1096-0309
Titre abrégé: Anal Biochem
Pays: United States
ID NLM: 0370535

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 05 10 2018
revised: 19 12 2018
accepted: 21 12 2018
pubmed: 27 12 2018
medline: 18 12 2019
entrez: 27 12 2018
Statut: ppublish

Résumé

l-Histidine analysis is essential in physiological research and clinical applications because l-histidine concentrations in biofluids are associated with various diseases. However, an enzymatic method for l-histidine quantitation has not yet been established. Here, we describe a novel l-histidine quantitation assay using a combination of histidine decarboxylase (HDC) and histamine dehydrogenase (HDH) enzymes. Wild-type HDC is unstable and completely lost its activity within 50 days of storage at 4 °C in solution. We rationally designed a HDC C57S mutant with markedly improved stability (storage at 4 °C for over 200 days) without altering the enzyme's substrate specificity. Together with HDH, the HDC C57S mutant was applied to quantify l-histidine concentrations in human plasma. The assay showed high precision (<2.0% inter-assay variation) and high accuracy (<5.8% deviation from the results of LC/MS).

Identifiants

pubmed: 30586560
pii: S0003-2697(18)30997-7
doi: 10.1016/j.ab.2018.12.017
pii:
doi:

Substances chimiques

Recombinant Proteins 0
Histidine 4QD397987E
Oxidoreductases Acting on CH-NH Group Donors EC 1.5.-
histamine dehydrogenase EC 1.5.99.-
Histidine Decarboxylase EC 4.1.1.22

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-20

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Hiroki Yamaguchi (H)

Institute for Innovation, Ajinomoto Co., Inc, Kawasaki, Kanagawa, 210-8681, Japan.

Kunio Nakata (K)

Institute for Innovation, Ajinomoto Co., Inc, Kawasaki, Kanagawa, 210-8681, Japan.

Moemi Tatsumi (M)

Institute for Innovation, Ajinomoto Co., Inc, Kawasaki, Kanagawa, 210-8681, Japan.

Masayuki Sugiki (M)

Institute for Innovation, Ajinomoto Co., Inc, Kawasaki, Kanagawa, 210-8681, Japan.

Hiroshi Miyano (H)

Institute for Innovation, Ajinomoto Co., Inc, Kawasaki, Kanagawa, 210-8681, Japan.

Toshimi Mizukoshi (T)

Institute for Innovation, Ajinomoto Co., Inc, Kawasaki, Kanagawa, 210-8681, Japan. Electronic address: toshimi_mizukoshi@ajinomoto.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH